Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer (NCT00898313)
Molecular Predictors of Lung Cancer Behavior
🩺 Plain-English Summary (8th-Grade Level)
RATIONALE: Using samples of blood, urine, sputum, and lung tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at molecular predictors of cancer in patients at high risk of lung cancer.
Who can join: Review the eligibility criteria below.
Location: Vanderbilt-Ingram Cancer Center — Nashville, Tennessee
Age range: 18 Years
🧪 Interventions in This Study
- comparative genomic hybridization (GENETIC)
- gene expression microarray analysis (GENETIC)
- proteomic profiling analysis (GENETIC)
- biologic sample preservation procedure (OTHER)
- nasal brushing (PROCEDURE)
- Blood draw (PROCEDURE)
- Urine collection (PROCEDURE)
- sputum sample (PROCEDURE)
- fluorescence bronchoscopy with airway biopsy (PROCEDURE)
- fine needle aspiration of the lung (PROCEDURE)
- thoracentesis (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Vanderbilt-Ingram Cancer Center — Nashville, Tennessee
- Veterans Affairs Medical Center - Nashville — Nashville, Tennessee
📞 Contact the Study Coordinator
Phone: (800) 811-8480
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Cancer
- Implementation Strategies for Monitoring Adherence in Real Time — Philadelphia, Pennsylvania
- Early Detection of Lung Cancer — Nashville, Tennessee
- Improving Utilization of Lung Cancer Screening in Underserved PA Populations — Allentown, Pennsylvania
- Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting — Houston, Texas
- Testing the Engaged Approach to Lung Cancer Screening — Denver, Colorado
- Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer — Boston, Massachusetts
Explore by condition: All Lung Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.